Real-Time Genetic Test During Brain Surgery Revolutionizes Glioma Treatment

In a breakthrough moment for brain cancer care, researchers funded by the National Cancer Institute (NCI) have developed a rapid genetic test capable of identifying critical mutations in glioma tumors while the patient is still in surgery. The results are delivered in less than 90 minutes, a dramatic improvement over the previous process that could take weeks.
This innovation brings real-time precision medicine directly into the operating room—giving surgeons and oncologists immediate insights to guide both surgical decisions and post-surgery treatment planning.
A Game-Changer for Glioma Patients
The test targets mutations in the IDH1 and IDH2 genes, which significantly influence how aggressive a glioma is and how it will respond to treatment.
Here’s how this test transforms care:
• Smarter Surgical Decisions: If the tumor has an IDH mutation (typically indicating slower growth), the surgeon may remove less tissue to preserve brain function. If the mutation is absent (indicating a more aggressive tumor), a more extensive resection may be warranted.
• Faster, Tailored Treatment: Real-time results mean the oncology team can immediately start planning targeted therapies, customized to the patient’s tumor biology—without weeks of delay waiting for traditional pathology reports.
A recent clinical study confirmed the test’s high accuracy and reliability, establishing it as a powerful tool for neurosurgeons and cancer specialists.
Raah-e-Aseman Foundation: A New Era in Brain Cancer Care
At the Raah-e-Aseman Charitable Foundation, we celebrate this advancement as a milestone in the mission toward personalized, compassionate cancer treatment.
This rapid test reduces not only the time to diagnosis but also the emotional toll patients face while waiting for results. It is a shining example of how modern science can directly improve patient outcomes and quality of life.
By enabling real-time, biology-informed surgical strategies, this breakthrough helps ensure that no moment in the cancer treatment journey is wasted—especially when every minute counts.
We commend the researchers, physicians, and institutions turning innovation into hope, and reaffirm our commitment to supporting cutting-edge approaches that make cancer care smarter, faster, and more human.

Source:
National Cancer Institute. (2025). During Brain Cancer Surgery, a Rapid Test Can Identify Mutations in Tumor Cells. Cancer Currents Blog.
🔗 Read the full article
.